AlphaFold predicted structure
LMOD2 · Q6P5Q4

Mean pLDDT
66.9/ 100
Low
547 residues
Confidence breakdown
- Very high(≥ 90)32%
- Confident(70–90)20%
- Low(50–70)14%
- Very low(< 50)34%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
leiomodin 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalPaediatric or syndromic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalcardiomyopathy, dilated, 2G
familial isolated dilated cardiomyopathy
dilated cardiomyopathy
hereditary disease
polycystic ovary syndrome
hypertrophic cardiomyopathy
Rare familial disorder with hypertrophic cardiomyopathy
left ventricular noncompaction
Arrhythmogenic right ventricular dysplasia
glycogen storage disease due to muscle and heart glycogen synthase deficiency
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Leiomodin-2
Mediates nucleation of actin filaments and thereby promotes actin polymerization (PubMed:18403713, PubMed:25250574, PubMed:26370058, PubMed:26417072). Plays a role in the regulation of actin filament length (By similarity). Required for normal sarcomere organization in the heart, and for normal heart function (PubMed:18403713)
LMOD2 · Q6P5Q4

Mean pLDDT
66.9/ 100
Low
547 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0